Bempedoic acid
Esperion
['cardio']
in the clear outcomes trial presented at #acc23/#wccardio, bempedoic acid decreased the risk of major cv events among adults with a history of #cvd or at high risk considered #statin intolerant. read more in : 
The latest news from the American College of Cardiology (ACC) and the 🌎 of cardiovascular health. Follow @ACCinTouch for other ACC updates.